Session Type
Meeting
Search Results for COVID-19
Abstract Number: 69
SHM Converge 2021
Background: The Coronavirus disease 2019 (COVID-19) was labeled a global pandemic rapidly. As of April 22nd, 2020, New York City became its epicenter, reporting differences in death rates among its 5 boroughs. The aim of this study was to investigate the mortality difference associated with hospital factors (teaching versus community hospital) in New York City. […]
Abstract Number: 72
SHM Converge 2021
Background: SARS-CoV-2, which has caused a global respiratory disease outbreak is also known to cause enteric infection and to present with gastrointestinal symptoms. Proton pump inhibitors (PPIs) are among the most commonly used medications in the U.S. and have been linked to possible adverse events such as an increased incidence of enteric infections and pneumonia. […]
Abstract Number: 75
SHM Converge 2021
Background: There has been conflicting data regarding the effect of comorbid asthma on severity of illness with COVID-19 disease. The prevalence of asthma reported in hospitalized patients as compared to the local population has varied widely across studies and areas of the world. Furthermore, the risk for testing positive for SARS-CoV-2 as well as the […]
Abstract Number: 82
SHM Converge 2021
Background: Novel coronavirus (COVID-19) has resulted in over 1 million deaths globally(1). Prognostic tools to identify high risk patients are crucial to guide resource allocation efforts(2). We aimed at developing a risk assessment tool for patients with COVID-19 based on the risk factors with most significant effect on hospital admission and in-hospital mortality. Methods: We […]
Abstract Number: 85
SHM Converge 2021
Background: Background: SARS-Cov-2 infection (COVID-19) can lead to severe respiratory illness characterized by diffuse pulmonary inflammation similar to what is seen in ARDS. The case series evaluates the additive anti-inflammatory effects of patients that received Tocilizumab, Convalescent Plasma and corticosteroids within 72 hours of hospital admission for critical COVID-19 disease. Methods: This is a retrospective […]
Abstract Number: 87
SHM Converge 2021
Background: Data about seroprevalence of COVID-19 infections in US Health Care Workers (HCW) is limited. CDC reported that about 55% of SARS-CoV-2 PCR positive HCWs reported exposure at work, with most of them being minimally symptomatic or asymptomatic(1). This study characterizes the symptomatic/asymptomatic SARS-CoV-2 seropositive frontline HCW in our hospital and correlate clinical features with […]
Abstract Number: 88
SHM Converge 2021
Background: Research surrounding COVID-19 (coronavirus disease 2019) is rapidly increasing, including the study of biomarkers for predicting outcomes. There is little data examining the correlation between serum albumin levels and COVID-19 disease severity. The purpose of this study is to evaluate whether admission albumin levels reliably predict outcomes in COVID-19 patients. Methods: We retrospectively reviewed […]
Abstract Number: 89
SHM Converge 2024
Background: With the advent of COVID-19 vaccinations, disparities in vaccination rates across various demographic groups especially in vulnerable population such as HIV positive patients have become an area of concern. Understanding these disparities and their underlying factors can provide essential insights for designing targeted interventions and optimizing vaccine distribution strategies. This study sought to investigate […]
Abstract Number: 90
SHM Converge 2021
Background: Patients with COVID-19 have increased rates of venous thromboembolism, however, there is currently no standardized approach to anticoagulation (AC) therapy particularly with respect to the proper dose of anticoagulation (prophylactic or therapeutic). Many observational studies have shown a mortality benefit in using prophylactic AC for hospitalized patients with COVID-19. A few studies have reported […]
Abstract Number: 93
SHM Converge 2021
Background: The SARS-CoV-2 (COVID-19) outbreak is rapidly spreading worldwide and as a result clinical predictors of disease severity are critical for appropriate management and disposition of patients. An early and accurate risk stratification of COVID-19 patients may have a great impact on their prognosis given rapid patient deterioration and continued need for rationing of treatments. […]